Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 22, 2024

BUY
$26.13 - $33.94 $26 - $33
1 Added 0.01%
9,495 $273,000
Q3 2023

Oct 18, 2023

BUY
$32.09 - $37.51 $1,508 - $1,762
47 Added 0.5%
9,494 $314,000
Q2 2023

Jul 19, 2023

SELL
$36.12 - $41.79 $135,450 - $156,712
-3,750 Reduced 28.42%
9,447 $346,000
Q1 2023

Apr 12, 2023

BUY
$39.39 - $51.28 $174,576 - $227,272
4,432 Added 50.56%
13,197 $538,000
Q3 2022

Oct 20, 2022

SELL
$43.76 - $53.42 $193,944 - $236,757
-4,432 Reduced 33.58%
8,765 $384,000
Q1 2022

Apr 28, 2022

BUY
$45.75 - $56.69 $179,660 - $222,621
3,927 Added 42.36%
13,197 $683,000
Q3 2021

Nov 03, 2021

BUY
$39.25 - $50.42 $97,536 - $125,293
2,485 Added 36.62%
9,270 $399,000
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $10,521 - $11,919
293 Added 4.51%
6,785 $266,000
Q4 2020

Feb 01, 2021

SELL
$33.47 - $42.56 $10,041 - $12,768
-300 Reduced 4.42%
6,492 $239,000
Q3 2020

Oct 30, 2020

BUY
$31.75 - $37.25 $9,525 - $11,175
300 Added 4.62%
6,792 $249,000
Q1 2020

Apr 23, 2020

SELL
$27.03 - $38.62 $10,730 - $15,332
-397 Reduced 5.76%
6,492 $212,000
Q4 2019

Jan 24, 2020

SELL
$32.92 - $37.36 $13,958 - $15,840
-424 Reduced 5.8%
6,889 $270,000
Q3 2019

Oct 18, 2019

SELL
$32.49 - $42.13 $18,356 - $23,803
-565 Reduced 7.17%
7,313 $263,000
Q2 2019

Jul 24, 2019

SELL
$36.98 - $41.52 $9,651 - $10,836
-261 Reduced 3.21%
7,878 $341,000
Q1 2019

Apr 29, 2019

BUY
$37.5 - $41.2 $202,462 - $222,438
5,399 Added 197.04%
8,139 $346,000
Q1 2019

Apr 25, 2019

SELL
$37.5 - $41.2 $211,275 - $232,120
-5,634 Reduced 67.28%
2,740 $336,000
Q4 2018

Jan 24, 2019

BUY
$38.47 - $43.86 $23,005 - $26,228
598 Added 7.69%
8,374 $366,000
Q3 2018

Oct 19, 2018

SELL
$34.47 - $41.81 $1,895 - $2,299
-55 Reduced 0.7%
7,776 $343,000
Q2 2018

Aug 08, 2018

BUY
$32.98 - $35.16 $258,266 - $275,337
7,831 New
7,831 $284,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Brand Asset Management Group, Inc. Portfolio

Follow Brand Asset Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brand Asset Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brand Asset Management Group, Inc. with notifications on news.